WPRO - Essential Drugs and Medicines Policy - Issue X (4), 2010. Special Issue on EC/ACP/WHO Partnership on Pharmaceutical Policies (Year 5)
(2010; 12 pages)


The outcome of the EC/ACP/WHO partnership, which began in 2004 to assist Pacific island countries (PICs) with pharmaceutical sector capacity building, was assessed in August 2009, its fifth year. The 4 million USD project aimed to enhance the accessibility, affordability and rational use of essential medicines in selected PICs, which comprise Cook Islands, Fiji, Kiribati, Marshall Islands, Federated States of Micronesia, Nauru, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu. The EC/ACP/WHO partnership had a significant impact on pharmaceutical sector development in these PICs. It supported PICs in drafting and revising national medicines policies, consulted World Trade Organization (WTO) members and observers on Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement safeguards and carried out medicines expenditure reviews. Medicines supply management in many PICs improved considerably, with supply chain reviews and establishment of computerized inventory systems. PICs also underwent national regulatory assessments, and rational use of medicines was promoted through training, campaigns and drafting and updating of standard treatment guidelines and essential medicines lists.

A participatory evaluation survey identified strengthening national medicines policies and drug supply management as the most useful assistance delivered...

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019